The Office of the Vice President for Research would like to share this opportunity with the research community. The goal of the Artificial Intelligence Molecular Screen (AIMS) program is to increase the number of scientists pursuing drug discovery. Atomwise, based in San Francisco, awards researchers with a customized virtual screen using cutting-edge Artificial Intelligence (AI) technology, free chemical compounds for physical screening, and technical support from medicinal chemists and computational biologists. The application deadline has been extended to September 21, 2018 and is available online at http://www.atomwise.com/aims/.
For more information, register for a free webinar:
"Introducing Atomwise's AIMS Awards Program - Supporting Academic Research in Drug Discovery with Free AI-Powered Virtual Screening and Compounds"
Register at https://zoom.us/webinar/register/9015356848241/WN_YTlD_xQDTWCyEVrTD5r7Bw
Date: Thursday, September 13, 2018
Time: 10am EDT
Note: Registration closes at the start of the webinar.
For more information, contact: Vaibhav Saini, Technology Commercialization Services at vaibhav.saini@uconn.edu